INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Free cash flow 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.1MFY2025 · since FY2016: $69.1M → -$31.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.1M | -224.4% |
| FY2024 | $25.0M | -65.8% |
| FY2023 | $73.1M | -67.1% |
| FY2022 | $222.1M | -16.0% |
| FY2021 | $264.4M | +60.3% |
| FY2020 | $164.9M | +1.9% |
| FY2019 | $161.9M | +32.8% |
| FY2018 | $121.9M | +71.7% |
| FY2017 | $71.0M | +2.8% |
| FY2016 | $69.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice